Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Merck & Co., Inc.MRK · Entity 2807 | Director | September 30, 2026 | October 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Merck & Co., Inc.
Report date September 30, 2026 · Filed October 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 21,490.4009 |
Reported balance
After 2026-09-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-30 · Grant · Acquired 55.9149 · Balance 21,490.4009 F1: 1-for-1 F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3: Holdings include shares acquired in dividend reinvestment transactions. |
| Common StockSEC Table I · non-derivative | Direct | 100 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 100 |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
F3: Holdings include shares acquired in dividend reinvestment transactions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 1, 2026 21:52 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 55.9149 | $145.31 | $8,124.99 |
DisclosureSEC source: 0000310158-26-000234 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,490.4009 Underlying: Common Stock · 55.9149 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 12:47 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 63.2296 | $128.50 | $8,125.00 |
DisclosureSEC source: 0000310158-26-000202 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,291.269 Underlying: Common Stock · 63.2296 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 18:19 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,853.0997 | $118.72 | $220,000.00 |
DisclosureSEC source: 0000310158-26-000161 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,228.0394 Underlying: Common Stock · 1,853.0997 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 17:47 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 67.5451 | $120.29 | $8,125.00 |
DisclosureSEC source: 0000310158-26-000076 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,238.3277 Underlying: Common Stock · 67.5451 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 17:22 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 77.1898 | $105.26 | $8,125.00 |
DisclosureSEC source: 0000310158-26-000006 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,025.6686 Underlying: Common Stock · 77.1898 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 13:31 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 96.8069 | $83.93 | $8,125.00 |
DisclosureSEC source: 0000310158-25-000053 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,775.7818 Underlying: Common Stock · 96.8069 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 16:08 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 102.6402 | $79.16 | $8,125.00 |
DisclosureSEC source: 0001127602-25-018465 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,495.8789 Underlying: Common Stock · 102.6402 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 17:22 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,863.0921 | $76.84 | $220,000.00 |
DisclosureSEC source: 0001127602-25-016370 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,393.2387 Underlying: Common Stock · 2,863.0921 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 13:57 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 90.5192 | $89.76 | $8,125.00 |
DisclosureSEC source: 0001127602-25-010926 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,377.6146 Underlying: Common Stock · 90.5192 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 18:57 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 81.6747 | $99.48 | $8,125.00 |
DisclosureSEC source: 0001127602-25-000275 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,164.7394 Underlying: Common Stock · 81.6747 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 18:16 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 71.5481 | $113.56 | $8,125.00 |
DisclosureSEC source: 0001127602-24-024643 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,977.3687 Underlying: Common Stock · 71.5481 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 17:25 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 65.63 | $123.80 | $8,124.99 |
DisclosureSEC source: 0001127602-24-019749 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,815.5246 Underlying: Common Stock · 65.63 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 19:00 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,752.4295 | $125.54 | $220,000.00 |
DisclosureSEC source: 0001127602-24-017597 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,749.8946 Underlying: Common Stock · 1,752.4295 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 28, 2024 Filed Mar 29, 2024 20:16 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 61.5764 | $131.95 | $8,125.01 |
DisclosureSEC source: 0001127602-24-011448 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,920.1071 Underlying: Common Stock · 61.5764 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:22 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 74.5276 | $109.02 | $8,125.00 |
DisclosureSEC source: 0001127602-24-000138 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,775.2157 Underlying: Common Stock · 74.5276 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 19:33 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 78.9218 | $102.95 | $8,125.00 |
DisclosureSEC source: 0001127602-23-025114 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,612.6101 Underlying: Common Stock · 78.9218 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:48 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 70.4134 | $115.39 | $8,125.00 |
DisclosureSEC source: 0001127602-23-020136 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,451.4933 Underlying: Common Stock · 70.4134 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Read SEC document |
| May 26, 2023 Filed May 31, 2023 18:55 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,980.7329 | $111.07 | $220,000.00 |
DisclosureSEC source: 0001127602-23-017190 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,381.0799 Underlying: Common Stock · 1,980.7329 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 76.37 | $106.39 | $8,125.00 |
DisclosureSEC source: 0001127602-23-011944 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,339.612 Underlying: Common Stock · 76.37 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 21:35 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 73.2312 | $110.95 | $8,125.00 |
DisclosureSEC source: 0001127602-23-000152 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,192.677 Underlying: Common Stock · 73.2312 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 15:50 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 94.3451 | $86.12 | $8,125.00 |
DisclosureSEC source: 0001127602-22-023383 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,039.0078 Underlying: Common Stock · 94.3451 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 18:05 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 89.1192 | $91.17 | $8,125.00 |
DisclosureSEC source: 0001127602-22-018671 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,871.9087 Underlying: Common Stock · 89.1192 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:24 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,363.5582 | $93.08 | $220,000.00 |
DisclosureSEC source: 0001127602-22-016178 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,782.7895 Underlying: Common Stock · 2,363.5582 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 17:39 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 198.05 | $82.05 | $16,250.00 |
DisclosureSEC source: 0001127602-22-010795 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,362.2803 Underlying: Common Stock · 198.05 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:09 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 212.0303 | $76.64 | $16,250.00 |
DisclosureSEC source: 0001127602-22-000431 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,105.0003 Underlying: Common Stock · 212.0303 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 15:33 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 216.3494 | $75.11 | $16,250.00 |
DisclosureSEC source: 0001127602-21-026163 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,840.424 Underlying: Common Stock · 216.3494 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 13:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 208.9495 | $77.77 | $16,250.00 |
DisclosureSEC source: 0001127602-21-021116 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,571.4316 Underlying: Common Stock · 208.9495 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. F4 · balance_after: Holdings reflect the adjustment that occurred as of June 2, 2021 in connection with the Organon spin-off as described in the registration statement on Form 10 filed with the SEC for Organon & Co. (the "Form 10"). As reported in the Form 10, each Merck phantom share outstanding under the Merck Deferred Compensation Plan as of immediately prior to the distribution date was converted on the distribution date into an adjusted Merck phantom share with the number of units represented by such award adjusted to preserve the aggregate value of the original Merck phantom shares as measured before and immediately after the distribution. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 18:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,635.3933 | $75.89 | $200,000.00 |
DisclosureSEC source: 0001127602-21-018665 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,173.1121 Underlying: Common Stock · 2,635.3933 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 18:55 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 210.7926 | $77.09 | $16,250.00 |
DisclosureSEC source: 0001127602-21-012552 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,509.5508 Underlying: Common Stock · 210.7926 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 21:24 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 198.6552 | $81.80 | $16,250.00 |
DisclosureSEC source: 0001127602-21-000543 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,274.6782 Underlying: Common Stock · 198.6552 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 195.9011 | $82.95 | $16,250.00 |
DisclosureSEC source: 0001127602-20-026349 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,054.2401 Underlying: Common Stock · 195.9011 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 16:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 210.1384 | $77.33 | $16,250.00 |
DisclosureSEC source: 0001127602-20-020747 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,837.9765 Underlying: Common Stock · 210.1384 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018483 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,627.8381 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:37 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 36.3361 | $76.94 | $2,795.70 |
DisclosureSEC source: 0001127602-20-012723 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150.1374 Underlying: Common Stock · 36.3361 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 21:24 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 113.8013 | $69.92 | $7,956.99 |
DisclosureSEC source: 0001127602-20-011293 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113.8013 Underlying: Common Stock · 113.8013 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.